Alvaro Pascual-Leone, MD, PhD, is Professor of Neurology at Harvard Medical School; Director of the Berenson-Allen Center for Noninvasive Brain Stimulation; Program Director of the Harvard-Thorndike Clinical Research Unit; and an Attending Neurologist at Beth Israel Deaconess Medical Center — all in Boston. He is a practicing behavioral neurologist and movement disorders specialist.
A native of Spain, Dr. Pascual-Leone received his M.D. in 1984 and his PhD in Neurophysiology in 1985, both from Albert-Ludwigs University in Freiburg, Germany. Following an internship in Medicine at Staedtisches Klinikum Karlsruhe in Germany and residency in Internal Medicine at Hospital Universitario de Valencia in Spain, Dr. Pascual-Leone completed a Neurology residency at the University of Minnesota, and then trained in Clinical Neurophysiology and Human Motor Control at the University of Minnesota and the National Institutes of Health (NIH). He joined Harvard Medical School and Beth Israel Deaconess Medical Center in 1997, after several years at the Cajal Institute of the Spanish Research Council.
Dr. Pascual-Leone is a world leader in research and development, clinical application and teaching of noninvasive brain stimulation. Dr. Pascual-Leone’s research aims at understanding the mechanisms that control brain plasticity across the life span to be able to modify them for the patient’s optimal behavioral outcome. Dr. Pascual-Leone has authored more than 450 scientific papers as well as several books, and holds various patents.
Dr Pascual-Leone is also the recipient of several international honors and awards, including the Ramón y Cajal Award in Neuroscience (Spain), the Norman Geschwind Prize in Behavioral Neurology from the American Academy of Neurology, the Friedrich Wilhelm Bessel Research Award from the Alexander von Humboldt Foundation (Germany), and the Jean-Louis Signoret Prize from the Ipsen Foundation (France). He is an elected member of the Spanish Royal Academy of Science (Farmacia). His work also has wide general public appeal and outreach through dissemination in articles in the lay press (Time Magazine, Newsweek, New Scientist, National Geographic) and documentaries on television and radio (Scientific American, 60 minutes, CNN, BBC, Discovery, National Geographic, etc.).
